PD-1

EXPERIENCE OF USING PD-1 CHECKPOINT INHIBITOR PROLGOLIMAB IN REAL CLINICAL PRACTICE IN A PATIENT WITH MULTIPLE METASTASES OF MELANOMA FROM AN UNKNOWN PRIMARY SITE

от

V.E. Askarov1, K.V. Menshikov1,2, Sh.I. Musin1, A.F. Nasretdinov1, N.I. Sultanbaeva1, I.A. Menshikova2, A.V. Sultanbaev1 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Askarov Vadim E. ― oncologist, head of the anti-tumor drug therapy department of the Republican Clinical Oncology Dispensary (Sterlitamak branch) 73/1 Oktyabrya Ave., Ufa, 450054, Russian Federation, e-mail: ufa.askarov@gmail.com, ORCID ID: … Читать далее

TARGETED THERAPY AND CELL TECHNOLOGIES IN PEDIATRIC HODGKIN LYMPHOMA TREATMENT

от

K.I. Utesheva, T.T. Valiev, K.I. Kirgizov, S.R. Varfolomeeva N.N. Blokhin National Medical Research Centre of Oncology, Moscow Utesheva Kristina I. ― pediatric oncologist of the Department of Pediatric Oncology and Hematology (Chemotherapy of Hemoblastosis) №1 of the Research Institute of Pediatric Oncology and Hematology at N.N. Blokhin National Medical Research Center of Oncology 23 Kashirskoe … Читать далее